Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas
Clinical trial NCT02849171 · COMPLETED
Trial details
- NCT number
- NCT02849171
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2022-05-06
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.